Joelle Straehla

Dr. Joelle Straehla

Dana-Farber Cancer Institute
+1
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2022 in Science
Verified
Journal Article
Closed access
NBNatalie Boehnke
Natalie Boehnke
Joelle StraehlaJoelle Straehla
Joelle Straehla
HSHannah C. Safford
Hannah C. Safford
MKMustafa Kocak
Mustafa Kocak
MRMatthew G. Rees
Matthew G. Rees
PHPaula Hammond
Paula Hammond
To accelerate the translation of cancer nanomedicine, we used an integrated genomic approach to improve our understanding of the cellular processes that govern nanoparticle trafficking. We developed a massively parallel screen that leverages barcoded, pooled cancer cell lines annotated with multiomic data to investigate cell association patterns across a nanoparticle library spanning a range of formulations with clinical potential. We identified both materials properties and cell-intrinsic features that mediate nanoparticle-cell association. Using machine learning algorithms, we constructed genomic nanoparticle trafficking networks and identified nanoparticle-specific biomarkers. We validated one such biomarker: gene expression ofSLC46A3, which inversely predicts lipid-based nanoparticle uptake in vitro and in vivo. Our work establishes the power of integrated screens for nanoparticle delivery and enables the identification and utilization of biomarkers to rationally design nanoformulations.

20 May 2024 in ACS Nano
Verified
Journal Article
Closed access
TAThomas Anchordoquy
Thomas Anchordoquy
NANatalie Artzi
Natalie Artzi
IBIrina V. Balyasnikova
Irina V. Balyasnikova
YBYechezkel Barenholz
Yechezkel Barenholz
Ninh La-BeckNinh La-Beck
Ninh La-Beck
Dmitri SimbergDmitri Simberg
Dmitri Simberg

20 November 2019 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
NBNatalie Boehnke
Natalie Boehnke
SCSantiago Correa
Santiago Correa
LHLiangliang Hao
Liangliang Hao
WWWade Wang
Wade Wang
Joelle StraehlaJoelle Straehla
Joelle Straehla
PHPaula Hammond
Paula Hammond

22 November 2023 in ACS Nano
Verified
Journal Article
Closed access
APAndrew J. Pickering
Andrew J. Pickering
NLNicholas G. Lamson
Nicholas G. Lamson
MMMichael H. Marand
Michael H. Marand
WHWei Hwang
Wei Hwang
Joelle StraehlaJoelle Straehla
Joelle Straehla
PHPaula Hammond
Paula Hammond

9 July 2014 in Cancer Biology & Therapy
Verified
Journal Article
Closed access
ETElizabeth Tarasewicz
Elizabeth Tarasewicz
RHRandala Hamdan
Randala Hamdan
Joelle StraehlaJoelle Straehla
Joelle Straehla
AHAshley Hardy
Ashley Hardy
OLOmar Nunez Lopez
Omar Nunez Lopez
JJJacqueline S Jeruss
Jacqueline S Jeruss
Cyclin D1/CDK4 activity is upregulated in up to 50% of breast cancers and CDK4-mediated phosphorylation negatively regulates the TGFβ superfamily member Smad3. We sought to determine if CDK4 inhibi...

1 May 2017 in Journal of Palliative Medicine
Verified
Journal Article
Closed access
Joelle StraehlaJoelle Straehla
Joelle Straehla
KBKrysta S. Barton
Krysta S. Barton
JYJoyce P. Yi-Frazier
Joyce P. Yi-Frazier
CWClaire Wharton
Claire Wharton
KBKevin Scott Baker
Kevin Scott Baker
ARAbby R. Rosenberg
Abby R. Rosenberg
Adolescents and early young adults (AYAs) with cancer are at high risk for poor outcomes. Positive psychological responses such as benefit-finding may buffer the negative impacts of cancer but are poorly understood in this population. We aimed to prospectively describe the content and trajectory of benefit- and burden-finding among AYAs to develop potential targets for future intervention. One-on-one semistructured interviews were conducted with English-speaking AYA patients (aged 14-25 years) within 60 days of diagnosis of a noncentral nervous system malignancy requiring chemotherapy, 6-12 and 12-18 months later. Interviews were coded using directed content analyses with a priori schema defined by existing theoretical frameworks, including changed sense of self, relationships, philosophy of life, and physical well-being. We compared the content, raw counts, and ratios of benefit-to-burden by patient and by time point. Seventeen participants at one tertiary academic medical center (mean age 17.1 years, SD = 2.7) with sarcoma (n = 8), acute leukemia (n = 6), and lymphoma (n = 3) completed 44 interviews with >100 hours of transcript-data. Average benefit counts were higher than average burden counts at each time point; 68% of interviews had a benefit-to-burden ratio >1. Positive changed sense-of-self was the most common benefit across all time points (44% of all reported benefits); reports of physical distress were the most common burden (32%). Longitudinal analyses suggested perceptions evolved; participants tended to focus less on physical manifestations and more on personal strengths and life purpose. AYAs with cancer identify more benefits than burdens throughout cancer treatment and demonstrate rapid maturation of perspectives. These findings not only inform communication practices with AYAs but also suggest opportunities for interventions to potentially improve outcomes.